Publications by authors named "H Kongsholm"
Article Synopsis
- In a trial for esophageal cancer, researchers tested irradiation alone and combined with bleomycin, finding no survival or symptom relief advantage from bleomycin.
- Female patients generally had better survival rates than males, though this was not significant in operable cases.
- Advanced disease patients treated with both bleomycin and adriamycin had longer survival, highlighting the importance of T1 tumors and radical surgery for better long-term outcomes.
Twenty-one consecutive patients with histologically confirmed glioblastoma multiforme were treated with prednimustine (130 mg/m2 for 5 days every 3 weeks) adjuvant to surgery and radiation therapy. A median survival of 8.7 months was obtained, and prednimustine seems to be of limited effectiveness.
View Article and Find Full Text PDFTen adult patients with severe atopic dermatitis were treated for three months with estatin, which is a metabolite of Streptomyces olivoreticuli. Bestatin has been shown to increase tumor resistance in mice, augment a variety of immune responses and to reduce the level of IgE in non-atopic healthy persons. During bestatin therapy we were not able to see any clinical change of the atopic dermatitis.
View Article and Find Full Text PDFTo evaluate the clinical effectiveness of intradermally injected bleomycin in saline and oil versus placebo, a double-blind study of 62 patients with 108 warts was made. Although bleomycin has been recommended in previous reports, we found no difference between the group treated with bleomycin and the placebo group.
View Article and Find Full Text PDF